Sanctuary Advisors LLC Makes New Investment in Chemed Corporation $CHE

Sanctuary Advisors LLC purchased a new stake in Chemed Corporation (NYSE:CHE) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,053 shares of the company’s stock, valued at approximately $490,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. Monetary Solutions Ltd purchased a new stake in Chemed during the fourth quarter worth approximately $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed in the 4th quarter valued at about $26,000. BOK Financial Private Wealth Inc. purchased a new stake in shares of Chemed during the fourth quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Chemed during the 2nd quarter worth $34,000. Finally, Versant Capital Management Inc lifted its position in Chemed by 7,500.0% in the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after purchasing an additional 75 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other news, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the transaction, the director owned 3,533 shares in the company, valued at approximately $1,879,556. This represents a 5.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the transaction, the chief executive officer owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. This trade represents a 2.76% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 6,537 shares of company stock worth $3,406,014. 3.33% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on CHE. Oppenheimer upped their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Bank of America reissued a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Royal Bank Of Canada raised their price objective on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Finally, Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $530.75.

Chemed Stock Performance

Shares of CHE stock opened at $523.57 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The stock has a market capitalization of $6.84 billion, a price-to-earnings ratio of 26.30, a PEG ratio of 1.98 and a beta of 0.51. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The company’s 50-day simple moving average is $509.45 and its 200-day simple moving average is $449.67.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same period last year, the business posted $4.27 earnings per share. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is presently 14.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.